Trial · NCT02730377
Adverse events362
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 362
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Liraglutide 1.8 mg | 65 | 980 | 82 |
| other | Nausea | Gastrointestinal disorders | Oral Antidiabetic Drug | 15 | 984 | 21 |
| serious | Abdominal pain lower | Gastrointestinal disorders | Liraglutide 1.8 mg | 0 | 980 | 0 |
| serious | Abdominal pain lower | Gastrointestinal disorders | Oral Antidiabetic Drug | 1 | 984 | 1 |
| serious | Acute kidney injury | Renal and urinary disorders | Liraglutide 1.8 mg | 6 | 980 | 7 |
| serious | Acute kidney injury | Renal and urinary disorders | Oral Antidiabetic Drug | 2 | 984 | 2 |
| serious | Acute myocardial infarction | Cardiac disorders | Liraglutide 1.8 mg | 5 | 980 | 5 |
| serious | Acute myocardial infarction | Cardiac disorders | Oral Antidiabetic Drug | 6 | 984 | 6 |
| serious | Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | Liraglutide 1.8 mg | 1 | 980 | 1 |
| serious | Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | Oral Antidiabetic Drug | 0 | 984 | 0 |
| serious | Anaemia | Blood and lymphatic system disorders | Liraglutide 1.8 mg | 1 | 980 | 1 |
| serious | Anaemia | Blood and lymphatic system disorders | Oral Antidiabetic Drug | 2 | 984 | 2 |
| serious | Angina pectoris | Cardiac disorders | Liraglutide 1.8 mg | 4 | 980 | 4 |
| serious | Angina pectoris | Cardiac disorders | Oral Antidiabetic Drug | 1 | 984 | 1 |
| serious | Angina unstable | Cardiac disorders | Liraglutide 1.8 mg | 0 | 980 | 0 |
| serious | Angina unstable | Cardiac disorders | Oral Antidiabetic Drug | 1 | 984 | 1 |
| serious | Ankle fracture | Injury, poisoning and procedural complications | Liraglutide 1.8 mg | 0 | 980 | 0 |
| serious | Ankle fracture | Injury, poisoning and procedural complications | Oral Antidiabetic Drug | 1 | 984 | 1 |
| serious | Anxiety | Psychiatric disorders | Liraglutide 1.8 mg | 0 | 980 | 0 |
| serious | Anxiety | Psychiatric disorders | Oral Antidiabetic Drug | 1 | 984 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02730377/events